Table 4.
Antimicrobial-resistance pattern of Gram-positive bacteria isolated from urinary catheterized inpatients of JUMC, Southwest Ethiopia, from February to August 2016.
| Antimicrobials | Antimicrobial resistance (%) | ||
|---|---|---|---|
| S. aureus (N=5) (N (%)) | CONS (N=7) (N (%)) | Total (N=12) (N (%)) | |
| AMP | 5 (100) | 7 (100) | 12 (100) |
| AML | 5 (100) | 7 (100) | 12 (100) |
| AMC | 3 (60) | 5 (71) | 8 (66.7) |
| CL | 5 (100) | 7 (100) | 12 (100) |
| CIP | 2 (40) | 2 (28.6) | 4 (33.3) |
| CRO | 2 (40) | 4 (57.1) | 6 (50) |
| GN | 5 (100) | 6 (86) | 11 (92) |
| F | 1 (20) | 2 (29) | 3 (25) |
| SXT | 5 (100) | 4 (57) | 9 (75) |
| Tet | 3 (60) | 5 (71) | 8 (67) |
| AK | 1 (20) | 2 (29) | 3 (25) |
| E | 4 (80) | 7 (100) | 11 (92) |
| P | 5 (100) | 7 (100) | 12 (100) |
| Ox | 5 (100) | 6 (86) | 11 (92) |
AMP: ampicillin; AML: amoxicillin; AMC: amoxicillin-clavulanic acid; CL: cephalexin; CIP: ciprofloxacin; GN: gentamicin; F: nitrofurantoin; SXT: trimethoprim/sulfamethoxazole; CRO: ceftriaxone; Tet: tetracycline; AK: amikacin; E: erythromycin; P: penicillin; Ox: oxacillin.